Northwest Cancer Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Endometrial cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• BriaCell Therapeutics Corporation1 trial
• Karyopharm Therapeutics Inc1 trial
• Processa Pharmaceuticals1 trial

Running trials

• Recruiting

  Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  NCT06072612· Phase 3· BriaCell Therapeutics Corporation· Source

  Contact: Mariela Abad

• Active, not recruiting

  Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

  NCT05611931· Phase 3· Karyopharm Therapeutics Inc· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer1 recruiting

Closed trials

• Terminated

  A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

  NCT06568692· Phase 2· Processa Pharmaceuticals· Source